MarketPeel
Insider Trading Intelligence
Pricing
…
ED

Erick Wayne Devinney

AXGN
CHIEF INNOVATION OFFICER · AXOGEN, INC. · CIK 0001595972
FILING MIX · LIFETIME55%/45%
BUYS
53
SELLS
44
TOTAL VALUE
$2.66M
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
11,575
AVG SELL PX
$20.12
TRADE KIND
SHOWING 97 / 97
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
7 backtested trades · 8 horizons · 8 pending
Forward-return performance of every backtestable P/S trade by Erick Wayne Devinney, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d7+28.57%+2.05%-0.04%+2.09%+2.95%—
14d7+28.57%+3.81%-0.51%+4.33%+2.92%—
30d7+28.57%+0.41%-0.06%+0.47%+0.63%—
60d7+28.57%+10.16%+4.14%+6.02%+13.00%—
90d7+42.86%+11.64%+5.43%+6.21%+1.45%—
180d7(1 pending)+16.67%+44.58%+10.63%+33.95%+21.22%—
1y7(3 pending)+50.00%+28.43%+20.97%+7.46%-7.08%—
2y7(4 pending)+66.67%+73.42%+13.40%+60.02%-47.61%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AXGN · 11,575 shares · as of Mar 16, 2026
068,728137,456206,184274,912202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 53 buys / 44 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AXGN
AXOGEN, INC.
PURCHASE
Chief Innovation Officer
11,575——268,002Mar 16, 2026Mar 18, 2026 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
Chief Innovation Officer
6,363——259,297Mar 16, 2026Mar 18, 2026 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
Chief Innovation Officer
6,363——6,363Mar 16, 2026Mar 18, 2026 ↗View →
AXGN
AXOGEN, INC.
SALE
Chief Innovation Officer
5,221$32.84$171.5K262,781Mar 16, 2026Mar 18, 2026 ↗View →
AXGN
AXOGEN, INC.
SALE
Chief Innovation Officer
2,870$32.84$94.3K256,427Mar 16, 2026Mar 18, 2026 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
Chief Innovation Officer
11,575——11,575Mar 16, 2026Mar 18, 2026 ↗View →
AXGN
AXOGEN, INC.
SALE
Chief Innovation Officer
11,276$30.65$345.6K252,934Mar 1, 2026Mar 2, 2026 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
33,780——274,912Feb 26, 2026Mar 2, 2026 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
23,000——23,000Feb 26, 2026Mar 2, 2026 ↗View →
AXGN
AXOGEN, INC.
SALE
Chief Innovation Officer
10,702$31.90$341.4K264,210Feb 26, 2026Mar 2, 2026 ↗View →
AXGN
AXOGEN, INC.
SALE
Chief Innovation Officer
19,517$31.21$609.1K241,132Dec 9, 2025Dec 10, 2025 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
40,000——260,649Dec 4, 2025Dec 5, 2025 ↗View →
AXGN
AXOGEN, INC.
SALE
Chief Innovation Officer
1,137$16.29$18.5K220,649Sep 16, 2025Sep 16, 2025 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
2,500——221,786Sep 13, 2025Sep 16, 2025 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
38,000——38,000Mar 25, 2025Mar 26, 2025 ↗View →
AXGN
AXOGEN, INC.
SALE
Chief Innovation Officer
15,111$17.50$264.4K217,762Mar 19, 2025Mar 19, 2025 ↗View →
AXGN
AXOGEN, INC.
SALE
Chief Innovation Officer
23,150——23,150Mar 16, 2025Mar 19, 2025 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
Chief Innovation Officer
23,150——232,873Mar 16, 2025Mar 19, 2025 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
Chief Innovation Officer
6,362——209,723Mar 16, 2025Mar 19, 2025 ↗View →
AXGN
AXOGEN, INC.
SALE
Chief Innovation Officer
6,362——6,363Mar 16, 2025Mar 19, 2025 ↗View →
AXGN
AXOGEN, INC.
SALE
Chief Innovation Officer
2,950——0Mar 16, 2025Mar 19, 2025 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
Chief Innovation Officer
2,950——203,361Mar 16, 2025Mar 19, 2025 ↗View →
AXGN
AXOGEN, INC.
SALE
Chief Innovation Officer
8,296$18.35$152.2K201,005Mar 4, 2025Mar 4, 2025 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
Chief Innovation Officer
24,799——209,301Feb 28, 2025Mar 4, 2025 ↗View →
AXGN
AXOGEN, INC.
SALE
Chief Innovation Officer
972$16.50$16.0K184,502Feb 25, 2025Feb 26, 2025 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
2,500——185,474Feb 22, 2025Feb 26, 2025 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
2,500——179,974Sep 13, 2024Sep 13, 2024 ↗View →
AXGN
AXOGEN, INC.
SALE
Chief Innovation Officer
721$7.68$5.5K167,890Mar 21, 2024Mar 25, 2024 ↗View →
AXGN
AXOGEN, INC.
SALE
Chief Innovation Officer
716$7.68$5.5K165,661Mar 21, 2024Mar 25, 2024 ↗View →
AXGN
AXOGEN, INC.
SALE
Chief Innovation Officer
3,141$7.68$24.1K177,474Mar 21, 2024Mar 25, 2024 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
Chief Innovation Officer
3,000——166,377Mar 16, 2024Mar 25, 2024 ↗View →
AXGN
AXOGEN, INC.
SALE
Chief Innovation Officer
3,000——0Mar 16, 2024Mar 25, 2024 ↗View →
AXGN
AXOGEN, INC.
SALE
Chief Innovation Officer
2,950——2,950Mar 16, 2024Mar 25, 2024 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
Chief Innovation Officer
2,950——168,611Mar 16, 2024Mar 25, 2024 ↗View →
AXGN
AXOGEN, INC.
SALE
Chief Innovation Officer
12,725——12,725Mar 16, 2024Mar 25, 2024 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
Chief Innovation Officer
12,725——180,615Mar 16, 2024Mar 25, 2024 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
50,000——163,377Mar 1, 2024Mar 5, 2024 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
68,600——68,600Feb 22, 2024Feb 23, 2024 ↗View →
AXGN
AXOGEN, INC.
SALE
VP Peripheral Nerve Science
864$4.04$3.5K113,377Oct 13, 2023Oct 13, 2023 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
1,579——114,241Jul 18, 2023Oct 13, 2023 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
VP Peripheral Nerve Science
3,000——113,596Mar 16, 2023Mar 20, 2023 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
VP Peripheral Nerve Science
5,900——112,431Mar 16, 2023Mar 20, 2023 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
46,300——46,300Mar 16, 2023Mar 20, 2023 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
64,000——64,000Mar 16, 2023Mar 20, 2023 ↗View →
AXGN
AXOGEN, INC.
SALE
VP Peripheral Nerve Science
1,835$8.27$15.2K110,596Mar 16, 2023Mar 20, 2023 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
VP Peripheral Nerve Science
5,900——5,900Mar 16, 2023Mar 20, 2023 ↗View →
AXGN
AXOGEN, INC.
SALE
VP Peripheral Nerve Science
934$8.27$7.7K112,662Mar 16, 2023Mar 20, 2023 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
VP Peripheral Nerve Science
3,000——3,000Mar 16, 2023Mar 20, 2023 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
VP Peripheral Nerve Science
20,000$5.09$101.8K116,752Dec 27, 2022Dec 28, 2022 ↗View →
AXGN
AXOGEN, INC.
SALE
VP Peripheral Nerve Science
20,000——0Dec 27, 2022Dec 28, 2022 ↗View →
AXGN
AXOGEN, INC.
SALE
VP Peripheral Nerve Science
10,784$9.44$101.8K105,968Dec 27, 2022Dec 28, 2022 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
VP Peripheral Nerve Science
750——0Dec 27, 2022Dec 29, 2022 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
VP Peripheral Nerve Science
750——106,718Dec 27, 2022Dec 29, 2022 ↗View →
AXGN
AXOGEN, INC.
SALE
VP Peripheral Nerve Science
187$9.44$1.8K106,531Dec 27, 2022Dec 29, 2022 ↗View →
AXGN
AXOGEN, INC.
SALE
VP Peripheral Nerve Science
405$8.40$3.4K96,752Jul 19, 2022Jul 18, 2022 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
1,579——94,157Jul 18, 2022Jul 18, 2022 ↗View →
AXGN
AXOGEN, INC.
SALE
VP Peripheral Nerve Science
6,000——6,000Mar 16, 2022Mar 18, 2022 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
25,450——25,450Mar 16, 2022Mar 18, 2022 ↗View →
AXGN
AXOGEN, INC.
SALE
VP Peripheral Nerve Science
1,497$7.97$11.9K92,578Mar 16, 2022Mar 18, 2022 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
VP Peripheral Nerve Science
6,000——94,075Mar 16, 2022Mar 18, 2022 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
23,738——23,738Mar 16, 2022Mar 18, 2022 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
1,181——88,432Feb 15, 2022Feb 17, 2022 ↗View →
AXGN
AXOGEN, INC.
SALE
VP Peripheral Nerve Science
357$8.42$3.0K88,075Feb 15, 2022Feb 17, 2022 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
VP Peripheral Nerve Science
750——87,436Dec 27, 2021Dec 29, 2021 ↗View →
AXGN
AXOGEN, INC.
SALE
VP Peripheral Nerve Science
187$9.74$1.8K87,249Dec 27, 2021Dec 29, 2021 ↗View →
AXGN
AXOGEN, INC.
SALE
VP Peripheral Nerve Science
750——750Dec 27, 2021Dec 29, 2021 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
VP Peripheral Nerve Science
575——86,830Dec 20, 2021Dec 22, 2021 ↗View →
AXGN
AXOGEN, INC.
SALE
VP Peripheral Nerve Science
144$9.24$1.3K86,686Dec 20, 2021Dec 22, 2021 ↗View →
AXGN
AXOGEN, INC.
SALE
VP Peripheral Nerve Science
575——0Dec 20, 2021Dec 22, 2021 ↗View →
AXGN
AXOGEN, INC.
SALE
VP Peripheral Nerve Science
10,000——0Dec 15, 2021Dec 16, 2021 ↗View →
AXGN
AXOGEN, INC.
SALE
VP Peripheral Nerve Science
4,171$8.80$36.7K86,255Dec 15, 2021Dec 16, 2021 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
VP Peripheral Nerve Science
10,000$3.67$36.7K90,426Dec 15, 2021Dec 16, 2021 ↗View →
AXGN
AXOGEN, INC.
SALE
VP Peripheral Nerve Science
392$19.20$7.5K80,426Jul 20, 2021Jul 21, 2021 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
1,580——80,818Jul 19, 2021Jul 21, 2021 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
VP of Clin. & Trans. Sciences
10,000$2.86$28.6K78,082Apr 28, 2021Apr 30, 2021 ↗View →
AXGN
AXOGEN, INC.
SALE
VP of Clin. & Trans. Sciences
10,000$2.86$28.6K0Apr 28, 2021Apr 30, 2021 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
11,800——11,800Mar 16, 2021Mar 18, 2021 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
23,500——23,500Mar 16, 2021Mar 18, 2021 ↗View →
AXGN
AXOGEN, INC.
SALE
VP, Clinical&Translational Sc
1,542$18.70$28.8K67,223Feb 17, 2021Feb 18, 2021 ↗View →
AXGN
AXOGEN, INC.
SALE
VP, Clinical&Translational Sc
322$18.70$6.0K68,082Feb 17, 2021Feb 18, 2021 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
1,181——68,404Feb 16, 2021Feb 18, 2021 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
5,050——68,765Feb 16, 2021Feb 18, 2021 ↗View →
AXGN
AXOGEN, INC.
SALE
VP, Clinical&Translational Sc
371$17.81$6.6K63,240Dec 29, 2020Dec 30, 2020 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
1,500——63,611Dec 27, 2020Dec 30, 2020 ↗View →
AXGN
AXOGEN, INC.
SALE
VP, Clinical&Translational Sc
147$16.42$2.4K62,111Dec 21, 2020Dec 22, 2020 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
575——62,258Dec 18, 2020Dec 22, 2020 ↗View →
AXGN
AXOGEN, INC.
SALE
VP, Clinical&Translational Sc
15,000——0Dec 15, 2020Dec 17, 2020 ↗View →
AXGN
AXOGEN, INC.
SALE
VP, Clinical&Translational Sc
4,373$16.50$72.2K61,683Dec 15, 2020Dec 17, 2020 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
VP, Clinical&Translational Sc
15,000$4.81$72.2K66,056Dec 15, 2020Dec 17, 2020 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
VP, Clinical&Translational Sc
2,530——0Apr 28, 2020Apr 28, 2020 ↗View →
AXGN
AXOGEN, INC.
PURCHASE
VP, Clinical&Translational Sc
2,530$0.27$68351,056Apr 28, 2020Apr 28, 2020 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
12,000——12,000Mar 16, 2020Mar 18, 2020 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
24,000——24,000Mar 16, 2020Mar 18, 2020 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
1,181——48,877Feb 18, 2020Feb 20, 2020 ↗View →
AXGN
AXOGEN, INC.
SALE
VP, Clinical&Translational Sc
351$14.68$5.2K48,526Feb 18, 2020Feb 20, 2020 ↗View →
AXGN
AXOGEN, INC.
SALE
VP, Clinical&Translational Sc
1,498$14.68$22.0K47,696Feb 18, 2020Feb 20, 2020 ↗View →
AXGN
AXOGEN, INC.
PURCHASEGRANT
Stock grant
5,049——49,194Feb 18, 2020Feb 20, 2020 ↗View →
Other insiders · AXGN
Loading peer insiders…
About this filer
CIK 0001595972
ROLE
Chief Innovation Officer
PRIMARY
AXGN
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001595972DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback